Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation - PubMed (original) (raw)
Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation
Charles I Ojielo et al. J Immunol. 2003.
Abstract
Bone marrow transplantation (BMT) is an important therapeutic option for a variety of malignant and nonmalignant disorders. Unfortunately, BMT recipients are at increased risk of infection, and in particular, pulmonary complications occur frequently. Although the risk of infection is greatest during the neutropenic period immediately following transplant, patients are still vulnerable to pulmonary infections even after neutrophil engraftment. We evaluated the risk of infection in this postengraftment period by using a well-established mouse BMT model. Seven days after syngeneic BMT, B6D2F(1) mice are no longer neutropenic, and by 3 wk, they demonstrate complete reconstitution of the peripheral blood. However, these mice remain more susceptible throughout 8 wk to infection after intratracheal administration of Pseudomonas aeruginosa; increased mortality in the P. aeruginosa-infected BMT mice correlates with increased bacterial burden in the lungs as well as increased systemic dissemination. This heightened susceptibility to infection was not secondary to a defect in inflammatory cell recruitment to the lung. The inability to clear P. aeruginosa in the lung correlated with reduced phagocytosis of the bacteria by alveolar macrophages (AMs), but not neutrophils, decreased production of TNF-alpha by AMs, and decreased levels of TNF-alpha and IFN-gamma in the bronchoalveolar lavage fluid following infection. Expression of the beta(2) integrins CD11a and CD11c was reduced on AMs from BMT mice compared with wild-type mice. Thus, despite restoration of peripheral blood count, phagocytic defects in the AMs of BMT mice persist and may contribute to the increased risk of infection seen in the postengraftment period.
Similar articles
- Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant.
Domingo-Gonzalez R, Katz S, Serezani CH, Moore TA, Levine AM, Moore BB. Domingo-Gonzalez R, et al. J Immunol. 2013 Jun 1;190(11):5809-17. doi: 10.4049/jimmunol.1203274. Epub 2013 Apr 29. J Immunol. 2013. PMID: 23630358 Free PMC article. - PTEN limits alveolar macrophage function against Pseudomonas aeruginosa after bone marrow transplantation.
Hubbard LL, Wilke CA, White ES, Moore BB. Hubbard LL, et al. Am J Respir Cell Mol Biol. 2011 Nov;45(5):1050-8. doi: 10.1165/rcmb.2011-0079OC. Epub 2011 Apr 28. Am J Respir Cell Mol Biol. 2011. PMID: 21527775 Free PMC article. - Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.
Ballinger MN, Hubbard LL, McMillan TR, Toews GB, Peters-Golden M, Paine R 3rd, Moore BB. Ballinger MN, et al. Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L114-22. doi: 10.1152/ajplung.00309.2007. Epub 2008 May 2. Am J Physiol Lung Cell Mol Physiol. 2008. PMID: 18456799 Free PMC article. - Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.
Lovewell RR, Patankar YR, Berwin B. Lovewell RR, et al. Am J Physiol Lung Cell Mol Physiol. 2014 Apr 1;306(7):L591-603. doi: 10.1152/ajplung.00335.2013. Epub 2014 Jan 24. Am J Physiol Lung Cell Mol Physiol. 2014. PMID: 24464809 Free PMC article. Review. - Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
Speert DP, Wong SY, Macdonald M, Sargeant R. Speert DP, et al. Behring Inst Mitt. 1997 Feb;(98):274-82. Behring Inst Mitt. 1997. PMID: 9382751 Review.
Cited by
- Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant.
Domingo-Gonzalez R, Katz S, Serezani CH, Moore TA, Levine AM, Moore BB. Domingo-Gonzalez R, et al. J Immunol. 2013 Jun 1;190(11):5809-17. doi: 10.4049/jimmunol.1203274. Epub 2013 Apr 29. J Immunol. 2013. PMID: 23630358 Free PMC article. - CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection.
Nagarkar DR, Wang Q, Shim J, Zhao Y, Tsai WC, Lukacs NW, Sajjan U, Hershenson MB. Nagarkar DR, et al. J Immunol. 2009 Nov 15;183(10):6698-707. doi: 10.4049/jimmunol.0900298. Epub 2009 Oct 28. J Immunol. 2009. PMID: 19864593 Free PMC article. - Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica.
Mann PB, Elder KD, Kennett MJ, Harvill ET. Mann PB, et al. Infect Immun. 2004 Nov;72(11):6650-8. doi: 10.1128/IAI.72.11.6650-6658.2004. Infect Immun. 2004. PMID: 15501798 Free PMC article. - Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant.
Coomes SM, Wilke CA, Moore TA, Moore BB. Coomes SM, et al. J Immunol. 2010 May 1;184(9):5130-40. doi: 10.4049/jimmunol.0901871. Epub 2010 Mar 26. J Immunol. 2010. PMID: 20348421 Free PMC article. - Protease-activated receptor 2 promotes clearance of Pseudomonas aeruginosa infection by inducing cAMP-Rac1 signaling in alveolar macrophages.
Rayees S, Joshi JC, Joshi B, Vellingiri V, Banerjee S, Mehta D. Rayees S, et al. Front Pharmacol. 2022 Sep 20;13:874197. doi: 10.3389/fphar.2022.874197. eCollection 2022. Front Pharmacol. 2022. PMID: 36204227 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials